TMO Thermo Fisher Scientific Inc.
Trend channel, buy level and 3-month target. Information only, not financial advice.
Above the channel · 3-year channel going sideways
Closed above resistance (US$638.87). The fitted trend may no longer apply.
- 3-year channel
- US$496.67 – US$638.87 · going sideways, +0% a year
- Price in channel
- 141% (0% = floor, 100% = ceiling)
- Ceiling overhead
- none — above both ceilings
- Turns bearish below
- US$496.67
Price history, with the path projected 3 months forward
Updated 6:50 AM ET (4 h ago)
- Daily close
- Upper trend line (3 years)
- Lower trend line (3 years)
- Dashed after today: projected 3 months
- Our buy
- Our target
Our target
No published call: price has closed 9.1% clear above the channel, so the fitted lines no longer describe where it is Levels below are for reference only.
Buy at or below
US$496.71
level as at 1 Nov 2026
Our target
US$640.31
by 2 Nov 2026
Projected move
28.9%
gross, before costs
Price is at or past our target.
6 settled calls · 3 reached target (50%) · average best move 7.2%. See the full record.
- Upper line touches
- 7
- Lower line touches
- 4
- Fit confidence
- 36%
- Fitted
- 1 Nov 2026
Company information
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Marc N. Casper
- Employees
- 125,000
- Country
- US
Scorecard
Our own scores from the fundamentals below (not Morningstar ratings).
- Valuation
- —
- Profitability
- —
- Financial health
- —
- Cash generation
- —
Key statistics
- Market cap
- US$260.36B
- Enterprise value
- —
- Beta
- 0.88
- Avg volume
- 2.17M
- Revenue per share
- —
- Dividend yield
- —
- 52-week range
- 435.27-710.84
- Exchange
- NYSE
Key ratios
- P/E (TTM)
- —
- PEG
- —
- Price / sales
- —
- Price / book
- —
- EV / EBITDA
- —
- Gross margin
- —
- Operating margin
- —
- Net margin
- —
- Current ratio
- —
- Quick ratio
- —
- Debt / equity
- —
- Interest cover
- —
Income statement
Balance sheet
Cash flow
Trend lines are fitted to past swing highs and lows and may not continue. Information only, not financial advice.